The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

RVX Insider Trading

Insider Ownership Percentage: 44.28%
Insider Buying (Last 12 Months): C$38,000.00
Insider Selling (Last 12 Months): C$0.00

Resverlogix Insider Trading History Chart

This chart shows the insider buying and selling history at Resverlogix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Resverlogix Share Price & Price History

Current Price: C$0.11
Price Change: Price Decrease of -0.01 (-8.33%)
As of 06/2/2023 01:00 AM ET

This chart shows the closing price history over time for RVX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

Resverlogix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/27/2022Donald J. MccaffreyDirectorBuy9,500C$0.25C$2,375.005,263,266
6/24/2022Donald J. MccaffreyDirectorBuy91,000C$0.25C$22,750.005,253,766
6/22/2022Donald J. MccaffreyDirectorBuy3,000C$0.25C$750.005,162,766
6/16/2022Donald J. MccaffreyDirectorBuy500C$0.25C$125.004,787,766
6/14/2022Donald J. MccaffreyDirectorBuy24,000C$0.25C$6,000.004,787,266
6/14/2022Donald J. MccaffreyDirectorBuy24,000C$0.25C$6,000.004,787,266
See Full Table
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

SEC Filings (Institutional Ownership Changes) for Resverlogix (TSE:RVX)

Resverlogix logo
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
Read More on Resverlogix

Today's Range

Now: C$0.11
Low: C$0.11
High: C$0.12

50 Day Range

MA: C$0.15
Low: C$0.11
High: C$0.21

52 Week Range

Now: C$0.11
Low: C$0.11
High: C$0.38

Volume

177,000 shs

Average Volume

107,472 shs

Market Capitalization

C$29.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.51

Who are the company insiders with the largest holdings of Resverlogix?

Resverlogix's top insider investors include:
  1. Donald J Mccaffrey (Director)
Learn More about top insider investors at Resverlogix.
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>